Cover Image

Population Pharmacokinetic Modeling and Simulation of TQ-B3101 to Inform Dosing in Pediatric Patients With Solid Tumors

Background: TQ-B3101 is a novel kinase inhibitor currently in development for the treatment of advanced malignant solid tumor and relapsed or refractory ALK-positive anaplastic large cell lymphoma.Methods: A population pharmacokinetic model was developed using data collected from a Phase 1 study and...

Full description

Saved in:

Bibliographic Details
Main Authors:	Fen Yang (Author), Huali Wu (Author), Yunhai Bo (Author), Ye Lu (Author), Hong Pan (Author), Su Li (Author), Qin Lu (Author), Simin Xie (Author), Harry Liao (Author), Bing Wang (Author)
Format:	Book
Published:	Frontiers Media S.A., 2022-01-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Population pharmacokinetic analysis of TQ-B3203 following intravenous administration of TQ-B3203 liposome injection in Chinese patients with advanced solid tumors
by: Xiaoqing Li, et al.
Published: (2023)

Population pharmacokinetic model for oral ORIN1001 in Chinese patients with advanced solid tumors
by: Xiaoqing Li, et al.
Published: (2024)

Comparative study: TQ and Lean Production ownership models in health services
by: Natalia Yuri Eiro, et al.
Published: (2015)

Simultaneous UPLC-TQ-MS/MS determination of six active components in rat plasma: application in the pharmacokinetic study of Cyclocarya paliurus leaves
by: Zi-Wan Ning, et al.
Published: (2019)

Translation and cultural adaptation of the Self-Talk Questionnaire for sports (S-TQ) into Brazilian Portuguese
by: Thiago Siqueira Paiva de Souza, et al.
Published: (2020)

PENENTUAN SPESIFIKASI PLAT BAJA HASIL UJI TABIK BERDASARKAN JIS (JAPANESE INDUSTRIAL STANDARDS) G 3101 DENGAN METODE UJI TARIK BAHAN
by: Sugandi, -
Published: (2008)

Thymoquinone (TQ) inhibits the replication of intracellular Mycobacterium tuberculosis in macrophages and modulates nitric oxide production
by: Hafij Al Mahmud, et al.
Published: (2017)

PROGRAMA CIÊNCIAS SEM FRONTEIRAS: ESTUDO DE CASO COM ESTUDANTES INTERCAMBIÁRIOS DA FATEC/TQ
by: Maria Aparecida Bovério, et al.
Published: (2019)

Safety, Stability, and Therapeutic Efficacy of Long-Circulating TQ-Incorporated Liposomes: Implication in the Treatment of Lung Cancer
by: Arif Khan, et al.
Published: (2022)

Qualitative and Quantitative Analysis of Phytochemicals in Sayeok-Tang via UPLC-Q-Orbitrap-MS and UPLC-TQ-MS/MS
by: Yu Jin Kim, et al.
Published: (2024)

Pharmacokinetics and Safety of Doripenem in Healthy Chinese Subjects and Monte Carlo Dosing Simulations
by: Yu Wang, et al.
Published: (2022)

Tacrolimus Pharmacokinetic and Pharmacogenomic Differences between Adults and Pediatric Solid Organ Transplant Recipients
by: Amy Lu, et al.
Published: (2010)

Pharmacokinetic equations versus Bayesian guided vancomycin monitoring: Pharmacokinetic model and model‐informed precision dosing trial simulations
by: Abdullah Aljutayli, et al.
Published: (2022)

Pharmacokinetically guided dosing of oral sorafenib in pediatric hepatocellular carcinoma: A simulation study
by: John C. Panetta, et al.
Published: (2021)

Population pharmacokinetics and dosing simulations of imipenem in serious bacteraemia in immunocompromised patients with febrile neutropenia
by: Sutep Jaruratanasirikul, et al.
Published: (2015)

Population Pharmacokinetics and Dosing Simulation of Vancomycin Administered by Continuous Injection in Critically Ill Patient
by: Romain Garreau, et al.
Published: (2021)

Population Pharmacokinetic Modelling and Simulation to Determine the Optimal Dose of Nanoparticulated Sorafenib to the Reference Sorafenib
by: Ki-Young Huh, et al.
Published: (2021)

DESI-TQ-MS imaging for ex vivo brain biodistribution assessment: evaluation of LBT-999, a ligand of the dopamine transporter (DAT)
by: Laurent Galineau, et al.
Published: (2024)

Constituents, Pharmacokinetics, and Pharmacology of Gegen-Qinlian Decoction
by: Jing-Ze Lu, et al.
Published: (2021)

A phase I evaluation of the effect of curcumin on dose‐limiting toxicity and pharmacokinetics of irinotecan in participants with solid tumors
by: Olumide B. Gbolahan, et al.
Published: (2022)

Development of a pediatric physiologically-based pharmacokinetic model to support recommended dosing of atezolizumab in children with solid tumors
by: Weize Huang, et al.
Published: (2022)

Prediction of α-Glucosidase Inhibitory Activity of LC-ESI-TQ-MS/MS-Identified Compounds from <i>Tradescantia pallida</i> Leaves
by: Fariha Imtiaz, et al.
Published: (2022)

Population Pharmacokinetic Analysis and Simulation of Alternative Dosing Regimens for Biosimilars to Adalimumab and Etanercept in Patients with Rheumatoid Arthritis
by: Stephanie F. Ling, et al.
Published: (2024)

Optimizing gentamicin dosing in different pediatric age groups using population pharmacokinetics and Monte Carlo simulation
by: Ragia H. Ghoneim, et al.
Published: (2021)

Dose Prediction and Pharmacokinetic Simulation of XZP-5610, a Small Molecule for NASH Therapy, Using Allometric Scaling and Physiologically Based Pharmacokinetic Models
by: Lei Zhang, et al.
Published: (2024)

Preparation, Characterization and Pharmacokinetics of Tolfenamic Acid-Loaded Solid Lipid Nanoparticles
by: Wei Xu, et al.
Published: (2022)

First-in-Human, Double-Blind, Randomized, Placebo-Controlled Trial of TQ-F3083, a New Dipeptidyl Peptidase-4 Inhibitor, in Healthy Chinese Adults
by: Jingrui Liu, et al.
Published: (2021)

Population pharmacokinetic modeling and simulation of maribavir to support dose selection and regulatory approval in adolescents with posttransplant refractory cytomegalovirus
by: Kefeng Sun, et al.
Published: (2023)

Preparation, characterization and pharmacokinetics of Cucurbitacin B solid dispersion
by: Qian Wu, et al.
Published: (2022)

Recent Approaches for Solid Dose Vaccine Delivery
by: Nishat Jahan, et al.
Published: (2019)

Prediction of a Therapeutic Dose for Buagafuran, a Potent Anxiolytic Agent by Physiologically Based Pharmacokinetic/Pharmacodynamic Modeling Starting from Pharmacokinetics in Rats and Human
by: Fen Yang, et al.
Published: (2017)

Bioactive Phenolics of the Genus Artemisia (Asteraceae): HPLC-DAD-ESI-TQ-MS/MS Profile of the Siberian Species and Their Inhibitory Potential Against α-Amylase and α-Glucosidase
by: Daniil N. Olennikov, et al.
Published: (2018)

Use of modeling and simulation to predict the influence of triazole antifungal agents on the pharmacokinetics of zanubrutinib and acalabrutinib
by: Lu Chen, et al.
Published: (2022)

Population Pharmacokinetic Modeling and Pharmacodynamic Target Attainment Simulation of Piperacillin/Tazobactam for Dosing Optimization in Late Elderly Patients with Pneumonia
by: Noriyuki Ishihara, et al.
Published: (2020)

Dosing Evaluation of Ceftazidime-Avibactam in Intensive Care Unit Patients Based on Pharmacokinetic/Pharmacodynamic (PK/PD) Modeling and Simulation
by: Hinojal Zazo, et al.
Published: (2024)

First-in-human study to investigate the safety and pharmacokinetics of salvianolic acid A and pharmacokinetic simulation using a physiologically based pharmacokinetic model
by: Jinliang Chen, et al.
Published: (2022)

Pharmacokinetics of Acetaminophen and Metformin Hydrochloride in Rats After Exposure to Simulated High Altitude Hypoxia
by: Jun-bo Zhu, et al.
Published: (2021)

Formulation Characterization and Pharmacokinetic Evaluation of Amorphous Solid Dispersions of Dasatinib
by: Sathish Dharani, et al.
Published: (2022)

Population pharmacokinetics, dosing optimization and clinical outcomes of biapenem in patients with sepsis
by: Dayu Chen, et al.
Published: (2024)

Optimal Teicoplanin Dosage Regimens in Critically Ill Patients: Population Pharmacokinetics and Dosing Simulations Based on Renal Function and Infection Type
by: Wang Y, et al.
Published: (2023)